 |
 |
 |
The Journal of the Japanese Society for Clinical Microbiology |
Biblioraphy Information
|
[Vol.31 No.2 contents] Japanese / English |
|
| ArticleTitle | A case of Laribacter hongkongensis bacteremia during AML chemotherapy |
| Language | J |
| AuthorList | Shigehiro Hagiwara1), Yukari Kaneda1), Yuichi Tanaka1), Tsugumi Yorikawa1), Aoi Nomura1), Yumiko Kimura2), Masashi Furuya3), Kiyofumi Ohkusu4), Hisanaga Sato1), Yoshihiro Masuda5) |
| Affiliation |
1) Department of Clinical Laboratory, Saiseikai Utsunomiya Hospital 2) Department of Clinical Laboratory, Jichi Medical University Hospital 3) Department of Clinical Laboratory, Haga Red Cross Hospital 4) Department of Microbiology, Tokyo Medical University 5) Department of Hematology, Saiseikai Utsunomiya Hospital |
| Publication | J.J.C.M.: 31 (2), 98-102, 2021 |
| Received | November 12, 2020 |
| Accepted | January 13, 2021 |
| Abstract | A 66-year-old man had a fever of 39.2°C during chemotherapy for recurrent AML. Therefore, blood cultures were collected in consideration of the possibility of bloodstream disease. Blood culture using aerobic bottles became positive on day 3, and a gram-negative spiral bacillus with a polar flagellum was confirmed. The bacterium was extracted directly from the blood culture fluid and identified as Laribacter hongkongensis via MALDI-TOF MS. In addition, molecular identification analysis revealed that the specimen had 99.8% homology with L. hongkongensis. In antimicrobial susceptibility testing, the MICs were low for carbapenems and quinolones. Therefore, carbapenems and quinolones are considered effective for invasive L. hongkongensis infections. |
| Keywords | Laribacter hongkongensis |
| Copyright © 2002 The Japanese Society for Clinical Microbiology All rights reserved. |